您的购物车当前为空
SARS-CoV-2 Mpro-IN-21 (compound A8) 是一种高效的SARS-CoV-2和COVID-19 Main Protease MPro抑制剂。在DPPH实验中展现出优异的抗氧化性能,IC50为0.36 mg/mL。此外,对Klebsiella具有显著的抑菌活性,其IC50为1.19 mg/mL。

SARS-CoV-2 Mpro-IN-21 (compound A8) 是一种高效的SARS-CoV-2和COVID-19 Main Protease MPro抑制剂。在DPPH实验中展现出优异的抗氧化性能,IC50为0.36 mg/mL。此外,对Klebsiella具有显著的抑菌活性,其IC50为1.19 mg/mL。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
SARS-CoV-2 Mpro-IN-21 相关产品
| 产品描述 | SARS-CoV-2 Mpro-IN-21 (compound A8) is an effective inhibitor of the SARS-CoV-2 and COVID-19 Main Protease MPro. It demonstrates significant antioxidant activity in the DPPH assay with an IC50 of 0.36 mg/mL. SARS-CoV-2 Mpro-IN-21 also shows notable antibacterial activity against Klebsiella, with an IC50 of 1.19 mg/mL. |
| 分子量 | 331.43 |
| 分子式 | C17H21N3O2S |
| CAS No. | 3041099-79-7 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容